Current Product Portfolio
Our portfolio of cardiovascular products consists of established devices and those in development. These devices increase physician choice and treatment options, but more importantly patient outcome.
The unrivalled design of the Aorfix™ stent graft addresses the shortcomings of first generation AAA stent grafts. These limitations are caused by lack of flexibility and difficulty of application, due to complex delivery systems and the inability of the stent graft to cope with aneurysm remodelling post-implant.
These limitations could lead to unnecessary re-interventions for the patient and therefore a reluctance for the physician to perform an otherwise clinically superior procedure.
